{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T07:22:18Z","timestamp":1794813738109,"version":"4.9.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T00:00:00Z","timestamp":1652572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T00:00:00Z","timestamp":1652572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science","award":["No. 21H03041"],"award-info":[{"award-number":["No. 21H03041"]}]},{"name":"a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science","award":["No. 19K09473"],"award-info":[{"award-number":["No. 19K09473"]}]},{"name":"a Grant-in-Aid for Research Activity Start-up from the Japan Society for the Promotion of Science","award":["No. 19K24023"],"award-info":[{"award-number":["No. 19K24023"]}]},{"name":"a Grant-in-Aid for Young Scientists from the Japan Society for the Promotion of Science","award":["20K17954"],"award-info":[{"award-number":["20K17954"]}]},{"name":"a research grant from the Takeda Science Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>NF2<\/jats:italic> alteration is the most commonly\u2013found genetic abnormality in meningiomas and is known to initiate events for aggressive-type meningiomas. Whereas the prognosis of meningiomas differs depending on their epigenomic\/transcriptomic profile, the effect of <jats:italic>NF2<\/jats:italic> alteration on the prognosis of benign meningiomas is not fully elucidated. This study aimed to probe the importance of <jats:italic>NF2<\/jats:italic> alteration in prognosis of WHO grade I meningiomas. A long-term retrospective follow-up (5.3\u2009\u00b1\u20094.5\u00a0years) study involving 281 consecutive WHO grade I meningioma patients was performed. We assessed tumour recurrence in correlation with extent of resection (EOR), histopathological findings, tumour location, and <jats:italic>NF2<\/jats:italic> alteration. \u201cNF2 meningioma\u201d was defined as meningiomas with presence of <jats:italic>NF2<\/jats:italic> mutation and\/or 22q loss. Overall, NF2 meningioma per se was not a predictor of prognosis in the whole cohort; however, it was a predictor of recurrence in supratentorial meningiomas, together with EOR and Ki-67. In a striking contrast, NF2 meningioma showed a better prognosis than non-NF2 meningioma in infratentorial lesion. Supratentorial NF2 meningiomas had higher Ki-67 and forkhead box protein M1 expression than those of others, possibly explaining the worse prognosis in this subtype. The combination of <jats:italic>NF2<\/jats:italic> alteration, high Ki-67 and supratentorial location defines subgroup with the worst prognosis among WHO grade I meningiomas. Clinical connotation of <jats:italic>NF2<\/jats:italic> alteration in terms of prognosis of WHO grade I meningioma differs in an opposite way between supratentorial and infratentorial tumors. Integrated anatomical, histopathological, and genomic classifications will provide the best follow-up schedule and proactive measures.<\/jats:p>","DOI":"10.1186\/s40478-022-01377-w","type":"journal-article","created":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T06:16:04Z","timestamp":1652595364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Clinical significance of NF2 alteration in grade I meningiomas revisited; prognostic impact integrated with extent of resection, tumour location, and Ki-67 index"],"prefix":"10.1186","volume":"10","author":[{"given":"Yu","family":"Teranishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6369-3391","authenticated-orcid":false,"given":"Satoru","family":"Miyawaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiichiro","family":"Ishigami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Hongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Dofuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Takami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Mitsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Ikemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Komura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Ushiku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumpei","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Nakatomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhito","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,15]]},"reference":[{"issue":"6","key":"1377_CR1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, Deimling AV, Figarella-Branger D, Cavenee WK et al (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803\u2013820","journal-title":"Acta Neuropathol"},{"issue":"6","key":"1377_CR2","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1227\/01.NEU.0000188281.91351.B9","volume":"57","author":"EB Claus","year":"2005","unstructured":"Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, Black PM (2005) Epidemiology of intracranial meningioma. Neurosurgery 57(6):1088\u20131095","journal-title":"Neurosurgery"},{"issue":"1","key":"1377_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3171\/2014.7.JNS131644","volume":"122","author":"L Rogers","year":"2015","unstructured":"Rogers L, Barani I, Chamberlain M, Kaley TJ, McDermott M, Raizer J et al (2015) Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg 122(1):4\u201323","journal-title":"J Neurosurg"},{"issue":"1","key":"1377_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3171\/jns.1985.62.1.0018","volume":"62","author":"RO Mirimanoff","year":"1985","unstructured":"Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL (1985) Meningioma: analysis of recurrence and progress-Sion following neurosurgical resection. J Neurosurg 62(1):18\u201324","journal-title":"J Neurosurg"},{"issue":"2","key":"1377_CR5","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0360-3016(97)00317-9","volume":"39","author":"KS Condra","year":"1997","unstructured":"Condra KS, Buatti JM, Mendenhall WM, Friedman WA, Marcus RB Jr, Rhoton AL (1997) Benign meningiomas: primary treatment selection affects survival. Int J Radiat Oncol Biol Phys 39(2):427\u2013436","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"1377_CR6","doi-asserted-by":"publisher","first-page":"936","DOI":"10.4065\/73.10.936","volume":"73","author":"SL Stafford","year":"1998","unstructured":"Stafford SL, Perry A, Suman VJ, Meyer FB, Scheithauer BW, Lohse CM et al (1998) Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin Proc 73(10):936\u2013942","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"1377_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.radonc.2004.01.006","volume":"71","author":"S Soyuer","year":"2004","unstructured":"Soyuer S, Chang EL, Selek U, Shi W, Maor MH, DeMonte F et al (2004) Radiotherapy after surgery for benign cerebral meningioma. Radiother Oncol 71(1):85\u201390","journal-title":"Radiother Oncol"},{"issue":"2","key":"1377_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0360-3016(98)90008-6","volume":"15","author":"BW Taylor Jr","year":"1988","unstructured":"Taylor BW Jr, Marcus RB Jr, Friedman WA, Ballinger WE Jr, Million RR (1988) The meningioma controversy: postoperative radiation therapy. Int J Radiat Oncol Biol Phys 15(2):299\u2013304","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1377_CR9","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/S0360-3016(02)04356-0","volume":"55","author":"BE Pollock","year":"2003","unstructured":"Pollock BE, Stafford SL, Utter A, Giannini C, Schreiner SA (2003) Stereotactic radiosurgery provides equivalent tumor control to Simpson Grade 1 resection for patients with small- to medium-size meningiomas. Int J Radiat Oncol Biol Phys 55(4):1000\u20131005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1377_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/BF00688260","volume":"73","author":"W Roggendorf","year":"1987","unstructured":"Roggendorf W, Schuster T, Peiffer J (1987) Proliferative potential of meningiomas determined with the monoclonal antibody Ki-67. Acta Neuropathol 73(4):361\u2013364","journal-title":"Acta Neuropathol"},{"issue":"12","key":"1377_CR11","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.prp.2010.09.002","volume":"206","author":"E Abry","year":"2010","unstructured":"Abry E, Thomassen I\u00d8, Salvesen \u00d8O, Torp SH (2010) The significance of Ki-67\/MIB-1 labeling index in human meningiomas: a literature study. Pathol Res Pract 206(12):810\u2013815","journal-title":"Pathol Res Pract"},{"key":"1377_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3171\/2012.3.JNS111945","volume":"117","author":"S Oya","year":"2012","unstructured":"Oya S, Kawai K, Nakatomi H, Saito N (2012) Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas. J Neuorsurg 117:121\u2013128","journal-title":"J Neuorsurg"},{"key":"1377_CR13","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3171\/2013.8.JNS13832","volume":"119","author":"Y Fukushima","year":"2013","unstructured":"Fukushima Y, Oya S, Nakatomi H, Shibahara J, Hanakita S, Tanaka S (2013) Effect of dural detachment on long-term tumor control for meningiomas treated using Simpson Grade IV resection. J Neuorsurg 119:1373\u20131379","journal-title":"J Neuorsurg"},{"key":"1377_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaa226","author":"MW Youngblood","year":"2020","unstructured":"Youngblood MW, Miyagishima DF, Jin L, Gupte T, Li C, Duran D et al (2020) Associations of meningioma molecular subgroup and tumor recurrence. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noaa226","journal-title":"Neuro Oncol"},{"key":"1377_CR15","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.3389\/fonc.2020.01522","volume":"10","author":"AF Haddad","year":"2020","unstructured":"Haddad AF, Young JS, Kanungo I, Sudhir S, Chen JS, Raleigh DR et al (2020) WHO Grade I meningioma recurrence: identifying high risk patients using histopathological features and the MIB-1 index. Front Oncol 10:1522","journal-title":"Front Oncol"},{"issue":"6123","key":"1377_CR16","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1126\/science.1233009","volume":"339","author":"VE Clark","year":"2013","unstructured":"Clark VE, Erson-Omay EZ, Serin A, Yin J, Cotney J, Ozduman K et al (2013) Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 339(6123):1077\u20131080","journal-title":"Science"},{"issue":"10","key":"1377_CR17","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/ng.3651","volume":"48","author":"VE Clark","year":"2016","unstructured":"Clark VE, Harmanc\u0131 AS, Bai H, Youngblood MW, Lee TI, Baranoski JF et al (2016) Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas. Nat Genet 48(10):1253\u20131259","journal-title":"Nat Genet"},{"issue":"3","key":"1377_CR18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/ng.2526","volume":"45","author":"PK Brastianos","year":"2013","unstructured":"Brastianos PK, Horowitz PM, Santagata S, Jones RT, McKenna A, Getz G et al (2013) Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet 45(3):285\u2013289","journal-title":"Nat Genet"},{"issue":"5","key":"1377_CR19","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/neuonc\/nov316","volume":"18","author":"M Abedalthagafi","year":"2016","unstructured":"Abedalthagafi M, Bi WL, Aizer AA, Merrill PH, Brewster R, Agarwalla PK et al (2016) Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Neuro Oncol 18(5):649\u2013655","journal-title":"Neuro Oncol"},{"key":"1377_CR20","unstructured":"Youngblood MW, Duran D, Montejo JD, Li C, Omay SB, Ozduman K et al (2019) Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas. J Neurosurg 1\u201310"},{"issue":"3","key":"1377_CR21","first-page":"345","volume":"19","author":"J Boetto","year":"2017","unstructured":"Boetto J, Bielle F, Sanson M, Peyre M, Kalamarides M (2017) SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas. Neuro Oncol 19(3):345\u2013351","journal-title":"Neuro Oncol"},{"issue":"1","key":"1377_CR22","doi-asserted-by":"publisher","first-page":"14433","DOI":"10.1038\/ncomms14433","volume":"8","author":"AS Harmanc\u0131","year":"2017","unstructured":"Harmanc\u0131 AS, Youngblood MW, Clark VE, Coskun S, Henegriu O, Duran D et al (2017) Integrated genomic analyses of de novo pathways underlying atypical meningiomas. Nat Commun 8(1):14433","journal-title":"Nat Commun"},{"issue":"43","key":"1377_CR23","doi-asserted-by":"publisher","first-page":"21715","DOI":"10.1073\/pnas.1912858116","volume":"116","author":"AJ Patel","year":"2019","unstructured":"Patel AJ, Wan YW, Al-Ouran R, Revelli JP, Cardenas MF, Oneissi M et al (2019) Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors. Proc Natl Acad Sci U S A 116(43):21715\u201321726","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1377_CR24","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","volume":"18","author":"F Sahm","year":"2017","unstructured":"Sahm F, Schrimpf D, Stichel D, Jones DTW, Hielscher T, Schefzyk S et al (2017) DNA methylation\u2013based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol 18(5):682\u2013694","journal-title":"Lancet Oncol"},{"issue":"7874","key":"1377_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41586-021-03850-3","volume":"597","author":"F Nassiri","year":"2021","unstructured":"Nassiri F, Liu J, Patil V, Mamatjan Y, Wang JZ, Hugh-White R et al (2021) A clinically applicable integrative molecular classification of meningiomas. Nature 597(7874):119\u2013125","journal-title":"Nature"},{"issue":"2","key":"1377_CR26","volume":"32","author":"AS Berghoff","year":"2022","unstructured":"Berghoff AS, Hielscher T, Ricken G, Furtner J, Scchrimpf D, Widhalm G et al (2022) Prognostic impact of genetic alterations and methylation classes in meningioma. Brain Pahtol 32(2):e12970","journal-title":"Brain Pahtol"},{"issue":"34","key":"1377_CR27","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1200\/JCO.21.00784","volume":"39","author":"SLN Maas","year":"2021","unstructured":"Maas SLN, Stichel D, Hielscher T, Sievers P, Berghoff AS, Schrimpf D, Sill M et al (2021) Integrated molecular-morphologic meningioma classification: a multicenter retrospective analysis, retrospectively and prospectively validated. J Clin Oncol 39(34):3839\u20133852","journal-title":"J Clin Oncol"},{"issue":"8","key":"1377_CR28","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1093\/neuonc\/noab036","volume":"23","author":"F Nassiri","year":"2021","unstructured":"Nassiri F, Wang JZ, Singh O, Karimi S, Dalcourt T, Ijad N et al (2021) Loss of H3K27me3 in meningiomas. Neuro Oncol 23(8):1282\u20131291","journal-title":"Neuro Oncol"},{"issue":"6","key":"1377_CR29","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.3390\/cancers13061262","volume":"13","author":"R Meta","year":"2021","unstructured":"Meta R, Boldt H, Kristensen BW, Sahm F, Sjursen W, Torp SH (2021) The prognostic value of methylation signatures and NF2 mutations in atypical meningiomas. Cancers (Basel) 13(6):1262","journal-title":"Cancers (Basel)"},{"key":"1377_CR30","doi-asserted-by":"crossref","unstructured":"Driver J, Hoffman S, Tavakol S, Woodward E, Maury EA, Bhave V et al (2021) A molecularly integrated grade for meningioma. Neuro Oncol (online ahead of print).","DOI":"10.14791\/btrt.2022.10.F-2747"},{"issue":"7","key":"1377_CR31","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/neuonc\/noz061","volume":"21","author":"F Nassiri","year":"2019","unstructured":"Nassiri F, Mamatjan Y, Suppiah S, Badhiwala JH, Mansouri S, Karimi S et al (2019) DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. Neuro Oncol 21(7):901\u2013910","journal-title":"Neuro Oncol"},{"issue":"5","key":"1377_CR32","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S1470-2045(17)30153-5","volume":"18","author":"M Sanson","year":"2017","unstructured":"Sanson M, Kalamarides M (2017) Epigenetics: a new tool for meningioma management? Lancet Oncol 18(5):569\u2013570","journal-title":"Lancet Oncol"},{"issue":"12","key":"1377_CR33","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.prp.2010.09.002","volume":"206","author":"E Abry","year":"2010","unstructured":"Abry E, Ingrid T, Salvesen O, Torp SH (2010) The significance of Ki-67\/MIB-1 labelling index in human meningiomas: a literature study. Pathol Res Pract 206(12):810\u2013815","journal-title":"Pathol Res Pract"},{"issue":"6","key":"1377_CR34","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/neuros\/nyaa226","volume":"87","author":"C Miran","year":"2020","unstructured":"Miran C, Skyrman S, Bartek J, Jensen LR, Kihlstrom L, Forander P et al (2020) The Ki-67 proliferation index as a marker of time to recurrence in intracranial meningioma. Neurosurgery 87(6):1289\u20131298","journal-title":"Neurosurgery"},{"key":"1377_CR35","unstructured":"Okano A. Miyawaki1 S, Hongo H, Dofuku S, Teranishi Y, Mitsui J et al (2021) Tumor locations of meningiomas based on embryologic origin of meninges determine the diversity of pathological diagnosis and genetic abnormality. Sci Rep. (in press)"},{"issue":"11","key":"1377_CR36","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1158\/2159-8290.CD-20-0160","volume":"10","author":"BC Prager","year":"2020","unstructured":"Prager BC, Vasudevan HN, Dixit D, Bernatchez JA, Wu Q, Wallace LC et al (2020) The meningioma enhancer landscape delineates novel subgroups and drives druggable dependencies. Cancer Discov 10(11):1722\u20131741","journal-title":"Cancer Discov"},{"issue":"11","key":"1377_CR37","doi-asserted-by":"publisher","first-page":"443369","DOI":"10.1101\/2021.05.11.443369","volume":"05","author":"C Blume","year":"2021","unstructured":"Blume C, Dogan D, Schweizer L, Peyre M, Doll S, Picard D et al (2021) Integrated phospho-proteogenomic and single-cell transcriptomic analysis of meningiomas establishes robust subtyping and reveals subtype-specific immune invasion. BioRxiv 05(11):443369. https:\/\/doi.org\/10.1101\/2021.05.11.443369","journal-title":"BioRxiv"},{"key":"1377_CR38","doi-asserted-by":"publisher","DOI":"10.1101\/2020.11.23.20237495","author":"A Choudhury","year":"2020","unstructured":"Choudhury A, Magill S, Eaton CD, Prager BC, Chen WC, Seo K et al (2020) Meningioma epigenetic grouping reveals biologic drivers and therapeutic vulnerabilities. MedRxiv. https:\/\/doi.org\/10.1101\/2020.11.23.20237495","journal-title":"MedRxiv"},{"issue":"5","key":"1377_CR39","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s41388-020-01568-6","volume":"40","author":"DM Fountain","year":"2021","unstructured":"Fountain DM, Smith MJ, O\u2019Leary C, Pathmanaban ON, Roncarioli F, Bobola N et al (2021) The spatial phenotype of phenotypically distinct meningiomas demonstrate potential implication of the embryology of the meninges. Oncogene 40(5):875\u2013884","journal-title":"Oncogene"},{"issue":"1","key":"1377_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00701-020-04650-w","volume":"163","author":"J Boetto","year":"2021","unstructured":"Boetto J, Peyre M, Kalamarides M (2021) Meningiomas from a developmental perspective: exploring the crossroads between meningeal embryology and tumorigenesis. Acta Neurochir (Wien) 163(1):57\u201366","journal-title":"Acta Neurochir (Wien)"},{"issue":"1","key":"1377_CR41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1136\/jnnp.20.1.22","volume":"20","author":"D Simpson","year":"1957","unstructured":"Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20(1):22\u201339","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1377_CR42","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3171\/2015.7.JNS15546","volume":"125","author":"A Mansouri","year":"2016","unstructured":"Mansouri A, Klironomos G, Taslimi S, Kilian A, Gentili F, Khan OH et al (2016) Surgically resected skull base meningiomas demonstrate a divergent postoperative recurrence pattern compared with non\u2013skull base meningiomas. J Neurosurg 125:431\u2013440","journal-title":"J Neurosurg"},{"issue":"6","key":"1377_CR43","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00401-018-1844-9","volume":"135","author":"LM Katz","year":"2018","unstructured":"Katz LM, Hielscher T, Liechty B, Silverman J, Zagzag D, Sen R et al (2018) Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence. Acta Neuropathol 135(6):955\u2013963","journal-title":"Acta Neuropathol"},{"issue":"13","key":"1377_CR44","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1016\/j.celrep.2018.03.013","volume":"22","author":"HN Vasudevan","year":"2018","unstructured":"Vasudevan HN, Braunstein SE, Phillips JJ, Pekmezci M, Tomlin B, Wu A et al (2018) Comprehensive molecular profiling identifies FOXM1 as a key transcription factor for meningioma proliferation. Cell Rep 22(13):3672\u20133683","journal-title":"Cell Rep"},{"issue":"1","key":"1377_CR45","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s40478-020-01040-2","volume":"8","author":"EA Williams","year":"2020","unstructured":"Williams EA, Santagata S, Wakimoto H, Shanker Gm, Barker FG 2nd, Sharaf R et al (2020) Distinct genomic subclasses of high-grade\/progressive meningiomas NF2-associated2-exclusive, and NF2-agnostic. Acta Neuropathol Commun. 8(1):171","journal-title":"Acta Neuropathol Commun."},{"issue":"5","key":"1377_CR46","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ccell.2015.04.002","volume":"27","author":"KW Pajtler","year":"2015","unstructured":"Pajtler KW, Witt H, Sill M, Jones DTW, Hovestadt V, Kratochwil F et al (2015) Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 27(5):728\u2013743","journal-title":"Cancer Cell"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01377-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-022-01377-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01377-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T06:23:01Z","timestamp":1652595781000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-022-01377-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,15]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1377"],"URL":"https:\/\/doi.org\/10.1186\/s40478-022-01377-w","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,15]]},"assertion":[{"value":"29 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"76"}}